BIOMAT Database Logo BIOMAT Database Logo

[Three cases of malignant lymphoma of the cervix uteri]. 1990

M Ohta, and K Mizuno, and H Kaseki, and S Iida, and Y Nishikawa, and T Ishihara, and Y Tokuhashi, and K Kuzuya
Department of Gynecology, Aichi Cancer Center.

UI MeSH Term Description Entries
D007770 L-Lactate Dehydrogenase A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist. Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

M Ohta, and K Mizuno, and H Kaseki, and S Iida, and Y Nishikawa, and T Ishihara, and Y Tokuhashi, and K Kuzuya
[Malignant lymphoma of the cervix uteri].
December 1978, Nowotwory,
M Ohta, and K Mizuno, and H Kaseki, and S Iida, and Y Nishikawa, and T Ishihara, and Y Tokuhashi, and K Kuzuya
[Non-Hodgkin's malignant lymphoma of the cervix uteri].
December 1993, Journal de chirurgie,
M Ohta, and K Mizuno, and H Kaseki, and S Iida, and Y Nishikawa, and T Ishihara, and Y Tokuhashi, and K Kuzuya
[Primary malignant non-Hodgkin's lymphoma of the cervix uteri].
February 2002, Presse medicale (Paris, France : 1983),
M Ohta, and K Mizuno, and H Kaseki, and S Iida, and Y Nishikawa, and T Ishihara, and Y Tokuhashi, and K Kuzuya
Malignant lymphoma of the cervix uteri: histology and ultrastructure.
August 1976, Journal of clinical pathology,
M Ohta, and K Mizuno, and H Kaseki, and S Iida, and Y Nishikawa, and T Ishihara, and Y Tokuhashi, and K Kuzuya
Three cases of amoebiasis of the cervix uteri.
May 1973, The Journal of obstetrics and gynaecology of the British Commonwealth,
M Ohta, and K Mizuno, and H Kaseki, and S Iida, and Y Nishikawa, and T Ishihara, and Y Tokuhashi, and K Kuzuya
[Lymphoma of the cervix uteri (report of 2 cases)].
July 1974, Ginecologia y obstetricia de Mexico,
M Ohta, and K Mizuno, and H Kaseki, and S Iida, and Y Nishikawa, and T Ishihara, and Y Tokuhashi, and K Kuzuya
[Lymphoma of cervix uteri (report of 2 cases)].
July 1974, Ginecologia y obstetricia de Mexico,
M Ohta, and K Mizuno, and H Kaseki, and S Iida, and Y Nishikawa, and T Ishihara, and Y Tokuhashi, and K Kuzuya
Primary malignant lymphoma of the cervix uteri: a case report.
April 1989, Singapore medical journal,
M Ohta, and K Mizuno, and H Kaseki, and S Iida, and Y Nishikawa, and T Ishihara, and Y Tokuhashi, and K Kuzuya
Lymphoma of the cervix uteri.
January 2009, BMJ case reports,
M Ohta, and K Mizuno, and H Kaseki, and S Iida, and Y Nishikawa, and T Ishihara, and Y Tokuhashi, and K Kuzuya
Malignant non-Hodgkin's-type lymphoma of the cervix uteri occurring during pregnancy.
June 1979, Gynecologic oncology,
Copied contents to your clipboard!